SCHEMBL6899294

SCHEMBL6899294

CC(=O)Oc1ccc2c(c1)[C@@H](O)CC1C2CC[C@]2(C)C=CCC12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
LMNA P02545 3/20 0.48
ADORA3 P0DMS8 2/20 0.48
ATM Q13315 2/20 0.48
PGR P06401 1/20 0.48
AR P10275 1/20 0.48
CHRM1 P11229 1/20 0.48
TBXA2R P21731 1/20 0.48
ADRA1A P35348 1/20 0.48
OPRM1 P35372 1/20 0.48
SLC6A3 Q01959 1/20 0.48
MAPK1 P28482 1/20 0.44
CYP3A4 P08684 2/20 0.44
MAPT P10636 2/20 0.44
TP53 P04637 1/20 0.44
ALDH1A1 P00352 1/20 0.39
NR1I3 Q14994 1/20 0.39
KMT2A Q03164 2/20 0.36
NR3C1 P04150 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2832847 1.00 ESR1 (0.48) ESR1SMN1; SMN2LMNAADORA3ATM
SCHEMBL2832843 1.00 ESR1 (0.48) ESR1SMN1; SMN2LMNAADORA3ATM
SCHEMBL7707677 1.00 ESR1 (0.48) ESR1SMN1; SMN2LMNAADORA3ATM
SCHEMBL4281671 0.82 ESR1 (0.63) ESR1SMN1; SMN2LMNAPGRAR
SCHEMBL2835305 0.82 ESR1 (0.63) ESR1SMN1; SMN2LMNAPGRAR
SCHEMBL6899123 0.82 ESR1 (0.63) ESR1SMN1; SMN2LMNAPGRAR
SCHEMBL1246985 0.82 LMNA (0.67) ESR1SMN1; SMN2LMNAADORA3ATM
SCHEMBL4284331 0.82 LMNA (0.67) ESR1SMN1; SMN2LMNAADORA3ATM
SCHEMBL7704864 0.81 ESR1 (0.45) ESR1SMN1; SMN2LMNAADORA3ATM
SCHEMBL2838358 0.81 HSD17B1 (0.47) ESR1SMN1; SMN2LMNAADORA3ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891188-A4 STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH PHERIN PHARM INC (US) 2004-09-01 EP disclosed
EP-0715517-B1 ESTRENE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION AND RELATED PHARMACEUTICAL COMPOSITIONS PHERIN PHARM INC (US) 2003-11-05 EP disclosed
US-6352980-B1 ADMINISTERING BY SPRAYING IN NOSE PHERIN PHARMACEUTICALS, INC. 2002-03-05 US disclosed
US-6331534-B1 ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN PHERIN PHARMACEUTICALS, INC. 2001-12-18 US disclosed
US-6140316-A NON-SYSTEMIC, NASAL ADMINISTRATION; TO AFFECT BEHAVIORAL OR PHYSIOLOGICAL RESPONSE IN HUMANS, E.G. A REDUCTION OF NEGATIVE AFFECT, MOOD, AND CHARACTER TRAITS PHERIN CORPORATION (US) 2000-10-31 US disclosed
US-6117860-A NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY PHERIN PHARMACEUTICALS, INC. (US) 2000-09-12 US disclosed
US-6066627-A ALTERING BLOOD CONCNETRATION OF LUTEINIZING HORMONE PHERIN CORPORATION (US) 2000-05-23 US disclosed
US-6057439-A EPOXYSTEROIDS PHERIN CORPORATION (US) 2000-05-02 US disclosed
US-5994568-A BIND TO NEUROEPITHELIAL RECEPTORS. PHERIN CORPORATION (US) 1999-11-30 US disclosed
US-5939570-A Estrenes for inducing hypothalamic effects PHERIN CORPORATION (US) 1999-08-17 US disclosed
US-5925774-A ESTRENE STEROIDS WHICH BIND TO NEUROEPITHELIAL RECEPTORS PHERIN CORPORATION (US) 1999-07-20 US disclosed
EP-0924219-A2 Novel estrenes for inducing hypothalamic effects PHERIN CORPORATION (US) 1999-06-23 EP disclosed
EP-0891188-A1 STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH Pherin Pharmaceuticals, Inc. (US) 1999-01-20 EP disclosed
US-5783571-A SUBSTITUTED TETRAENE STEROIDS FOR CONTROLLING GLANDULAR FUNCTION PHERIN CORPORATION (US) 1998-07-21 US disclosed
US-5633392-A STIMULANTS FOR AUTONOMIC NERVOUS SYSTEM; NOSE SPRAYING PHERIN CORPORATION (US) 1997-05-27 US disclosed